ATE73137T1 - 11-arylsteroid-derivate. - Google Patents

11-arylsteroid-derivate.

Info

Publication number
ATE73137T1
ATE73137T1 AT88200071T AT88200071T ATE73137T1 AT E73137 T1 ATE73137 T1 AT E73137T1 AT 88200071 T AT88200071 T AT 88200071T AT 88200071 T AT88200071 T AT 88200071T AT E73137 T1 ATE73137 T1 AT E73137T1
Authority
AT
Austria
Prior art keywords
carbon atoms
group
hydrocarbon
oxo
saturated
Prior art date
Application number
AT88200071T
Other languages
English (en)
Inventor
Hubert Jan Jozef Loozen
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of ATE73137T1 publication Critical patent/ATE73137T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
AT88200071T 1987-01-23 1988-01-18 11-arylsteroid-derivate. ATE73137T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8700157 1987-01-23
EP88200071A EP0277676B1 (de) 1987-01-23 1988-01-18 11-Arylsteroid-Derivate

Publications (1)

Publication Number Publication Date
ATE73137T1 true ATE73137T1 (de) 1992-03-15

Family

ID=19849457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88200071T ATE73137T1 (de) 1987-01-23 1988-01-18 11-arylsteroid-derivate.

Country Status (16)

Country Link
EP (1) EP0277676B1 (de)
JP (1) JP2664390B2 (de)
KR (1) KR960013448B1 (de)
CN (1) CN1030081C (de)
AT (1) ATE73137T1 (de)
AU (1) AU603637B2 (de)
CA (1) CA1339570C (de)
DE (1) DE3868647D1 (de)
DK (1) DK163307C (de)
ES (1) ES2031991T3 (de)
FI (1) FI89054C (de)
GR (1) GR3004783T3 (de)
IE (1) IE60780B1 (de)
NZ (1) NZ223262A (de)
PT (1) PT86602B (de)
ZA (1) ZA88317B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2785023B2 (ja) * 1987-12-30 1998-08-13 ルセル―ユクラフ １７α位置を置換された１７β―ＯＨ―１９―ノルステロイドの新誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
DE69034035T2 (de) * 1989-07-07 2004-01-22 Endorecherche Inc., Ste-Foy Methode zur behandlung androgenbedingter krankheiten
AU5856090A (en) * 1989-07-07 1991-02-06 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity
DE59010853D1 (de) * 1989-08-04 1998-12-03 Schering Ag 11 Beta-Aryl-gona-4,9-dien-3-one
FR2650748B1 (fr) * 1989-08-08 1991-11-08 Roussel Uclaf Nouveaux esters d'acides organiques avec des alcools derives de 19-nor steroides et leurs sels, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions les renfermant
DE4018167A1 (de) * 1990-06-01 1991-12-05 Schering Ag Verfahren zur herstellung von 10(beta)-h-steroiden
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
ZA929315B (en) * 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
AU680818B2 (en) * 1992-05-21 1997-08-14 Endorecherche Inc. Improved antiandrogens
KR950701527A (ko) * 1992-05-21 1995-04-28 라브리 페르낭 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)
BR9307866A (pt) * 1993-06-15 1996-07-30 Pherin Corp Esteróides estreno como iniciadores neuroquímicos de mudança em funçao hipotalamica humana e composiçoes farmaceuticas relacionadas e processos
DE4415590A1 (de) * 1994-04-28 1995-11-02 Schering Ag Verfahren zur stereoselektiven Einführung einer Alkinylseitenkette an 11ß-Aryl-substituierten 13alpha-Alkylgonan-17-onen
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
CA2359218A1 (en) * 1999-03-08 2000-09-14 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
ES2258037T3 (es) * 1999-12-02 2006-08-16 Akzo Nobel N.V. Androgenos sustituidos con 14,15-beta-metilen.
BR0016092A (pt) * 1999-12-02 2002-07-30 Akzo Nobel Nv Composto, uso de um composto kit para contracepção hormonal em um macho, e, método de tratamento
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
EP2582713A1 (de) 2010-06-17 2013-04-24 MSD Oss B.V. (11-beta,17-alpha )-11-(4-(2-11c-acetyl)phenyl)-17,23-epoxy-19,24-dinorchola-4,9,20-trien-3-on
BR112013030830B1 (pt) 2011-06-01 2019-12-03 Estetra S A processo para a preparação de um composto de fórmula (i) e processo de preparação de estetrol
KR101957937B1 (ko) 2011-06-01 2019-03-14 에스테트라 에스.피.알.엘. 에스테트롤 중간체의 제조 방법
EP2383279A1 (de) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Herstellungsverfahren für Esterol
CN113559075A (zh) 2014-11-17 2021-10-29 康泰科思特生物制药公司 奥那司酮延长释放组合物和方法
US10548905B2 (en) 2015-12-15 2020-02-04 Context Biopharma Inc. Amorphous onapristone compositions and methods of making the same
WO2018102369A1 (en) 2016-11-30 2018-06-07 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection
CN110437294A (zh) * 2019-07-21 2019-11-12 浙江神洲药业有限公司 一种制备群勃龙醋酸酯的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
ES8502612A1 (es) * 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos

Also Published As

Publication number Publication date
JPS63216895A (ja) 1988-09-09
FI89054C (fi) 1993-08-10
FI880257A0 (fi) 1988-01-21
KR880009036A (ko) 1988-09-13
EP0277676B1 (de) 1992-03-04
DK30488A (da) 1988-07-24
EP0277676A1 (de) 1988-08-10
DE3868647D1 (de) 1992-04-09
IE880103L (en) 1988-07-23
FI880257A (fi) 1988-07-24
FI89054B (fi) 1993-04-30
PT86602B (pt) 1991-12-31
ES2031991T3 (es) 1993-01-01
JP2664390B2 (ja) 1997-10-15
KR960013448B1 (ko) 1996-10-05
GR3004783T3 (de) 1993-04-28
AU1066988A (en) 1988-07-28
NZ223262A (en) 1989-08-29
CN1030081C (zh) 1995-10-18
CA1339570C (en) 1997-12-09
DK163307B (da) 1992-02-17
CN88100979A (zh) 1988-08-17
DK30488D0 (da) 1988-01-22
DK163307C (da) 1992-07-06
PT86602A (pt) 1988-02-01
ZA88317B (en) 1988-07-27
AU603637B2 (en) 1990-11-22
IE60780B1 (en) 1994-08-10

Similar Documents

Publication Publication Date Title
ATE73137T1 (de) 11-arylsteroid-derivate.
ES8300716A1 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
ES474288A1 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos
ES2053714T3 (es) Proceso para la preparacion de 11-arilesteroides.
FI881826A (fi) Nya 11-aryloestran och 11-arylopregnanderivat.
KR850004472A (ko) 4h-3,i-벤즈옥사진-4-온 유도체의 제조방법
HU9401427D0 (en) 19-nor steroide derivatives, process for producing them and compositions containing them
EP0308145A3 (de) Mylbemycin-Derivate mit antiparasitärer Wirkung
ES8205224A1 (es) Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilios 6-1-y 2-sustituidos.
DE3266922D1 (en) At position 17 esterified and at position 21 thio-esterified steroids, process for their preparation and their utilisation as pharmaceutical preparations
GB1435481A (en) Process for isolation of dipeptide esters
GB1390725A (en) Benzimidazole derivatives process for their preparation and compositoons incorporating them
TH1366A (th) อนุพันธ์ของฟอสฟอรัสของคาร์บามิมิโดไธโออิคแอซิต เอสเทอร์

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee